Visionary Ventures

Visionary Ventures is a Newport Beach-based venture capital firm guided by key opinion leaders to invest exclusively in the ophthalmology and vision care sectors. The KOL-led model means clinical expertise from practicing ophthalmologists is embedded in deal selection and diligence, an unusual structure outside specialist life sciences funds. Founders building ophthalmic surgical devices, retinal imaging, glaucoma diagnostics and therapeutics, dry eye products, intraocular lenses, ophthalmic drug delivery, or vision-focused digital health platforms fit the thesis. The firm operates in a category where clinical adoption depends heavily on surgeon and KOL endorsement, making the model especially relevant.

The fund invests at Series A and Series B with check sizes of $1M to $5M. It is based in the United States and operates across medical devices and MedTech alongside pharma and therapeutics, both filtered through ophthalmology. There is no stated AI focus.

Founders should expect technical and clinical diligence led by practicing ophthalmologists, including evaluation of how the technology fits real-world surgical and clinic workflows. A clear regulatory pathway, KOL engagement plan, and reimbursement strategy strengthen positioning. Limited public information is available about all named partners and complete portfolio companies. Warm introductions via ophthalmic society networks, ASCRS, AAO, or referrals from practicing ophthalmologists who advise the fund are typically the most effective routes in.